Back

Daily-life and work activities are more impaired in individuals with long covid who present cardiopulmonary symptoms: preliminary results from a cross-sectional assessment

25 April 2024 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: COVID-19 and long COVID Environmental and Occupational Aspects of Heart Disease Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Cassia Luz Goulart

Hospital de Clínicas de Porto Alegre, Porto Alegre (Brazil)

7 More presentations in this session

Presentation thumbnail
Pro-inflammatory cytokines are elevated two-years after acute severe COVID-19: a pre-vaccine, two-years, five-point longitudinal assessment of individuals with Long COVID.
Doctor C. Luz Goulart (Porto Alegre, BR)
Abstract Slides
Presentation thumbnail
The impact of cardiorespiratory fitness on COVID-19 related outcomes: the ETHOS Study
Professor J. Myers (Palo Alto, US)
Abstract Slides
Presentation thumbnail
Increased incidence of arrhythmias, heart failure and thrombosis in COVID-19 patients after the first 3 months post-infection: a population-based cohort study
Associate Professor I. Roman Degano (Vic, ES)
Abstract Slides
Presentation thumbnail
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study.
Ms S. Polo-Alonso (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study
Mr E. Eriksen (Oslo, NO)
Abstract Slides

Access the full session

Session thumbnail
COVID-19 and long COVID

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Occupational cardiology: where are the opportunities for cardiovascular prevention?
thumbnail
Webinar
Climate change and cardiovascular disease
thumbnail
Congress Presentation
Different types of environmental pollution: same effect on cardiovascular risk?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources